UBS Group’s Foley Trasimene Acquisition Corp. II BFT Stock Holding History

UBS Group’s Portfolio BFT Stock Details BFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,848	Closed	-$587K	–	9850
2020 Q4	$587K	Buy	+38,848	New	+$443K	﹤0.01%	4480

Other funds holding BFT

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

UBS Group's BFT Position: Q1 2021 in Review

UBS Group sold out of Foley Trasimene Acquisition Corp. II (BFT) in Q1 2021, closing a stake of 38,848 shares — an estimated $587K sold.

UBS Group first reported a position in BFT in Q4 2020 and held it in 1 quarter. The position peaked at $587K in Q4 2020. 3 funds tracked by Wall St. Rank hold BFT as of Q1 2021.

UBS Group reported no remaining Foley Trasimene Acquisition Corp. II position as of Q1 2021 after selling out during the quarter.
UBS Group sold 38,848 Foley Trasimene Acquisition Corp. II shares in Q1 2021, an estimated $587K.
UBS Group first reported a position in Foley Trasimene Acquisition Corp. II in Q4 2020 and held it in 1 quarter.
UBS Group's Foley Trasimene Acquisition Corp. II position peaked at $587K in Q4 2020.
3 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.